STAND. COM. REP. NO. 922-04
Honolulu, Hawaii
, 2004
RE: S.B. No. 2950
S.D. 1
Honorable Calvin K.Y. Say
Speaker, House of Representatives
Twenty-Second State Legislature
Regular Session of 2004
State of Hawaii
Sir:
Your Committee on Health, to which was referred S.B. No. 2950, S.D. 1, entitled:
"A BILL FOR AN ACT RELATING TO GENERIC SUBSTITUTION OF PRESCRIPTION DRUG PRODUCTS,"
begs leave to report as follows:
The purpose of this bill is to clarify the law pertaining to substitution of generic prescription drugs by, among other things:
(1) Adding and amending definitions;
(2) Replacing the state drug formulary with the Hawaii additions and deletions list or compedia of therapeutically equivalent generic drug products; and
(3) Removing the provision that prohibits the substitution of anti-epileptic drugs without consent.
The Department of Health, Hawaii Pharmacists Association, Kaiser Permanente, and Hawaii Medical Service Association testified in support of this bill.
Your Committee finds that products approved by the Food and Drug Administration as safe, effective, and therapeutically equivalent should be allowed to be used as therapeutically equivalent generic substitutes. This bill will enhance the public's access to safe, low-cost drug products.
As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 2950, S.D. 1, and recommends that it pass Second Reading and be referred to the Committee on Consumer Protection and Commerce.
Respectfully submitted on behalf of the members of the Committee on Health,
|
____________________________ DENNIS A. ARAKAKI, Chair |
||